document.write('
Feb 14, 2024 
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
Feb 8, 2024 
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Dec 26, 2023 
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
Dec 12, 2023 
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC
')